CoChat

PEX-168 improves insulin resistance, inflammatory response and adipokines in simple obese mice: a mechanistic exploration

Open access
Guo, Zeyuan, Wu, Yuting, Zhu, Lihua, Wang, Yong, Wang, Daorong, Sun, Xiaofang · 2021 · BMC Endocrine Disorders

Published version of a preprint

The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.

Abstract

Background: Polyethylene glycol loxenatide (PEX-168) is a new antidiabetic drug; as such, there are not yet any reports on its weight loss effect. Therefore, this trial was designed to investigate the effect of PEX-168 on simple obese mice. Methods: Thirty healthy male C57BL/6 mice were randomly selected and divided into a control group (NC) and an obesity model group. The high-fat diet-induced simple obesity mice were divided into a model control group (HF) and three intervention groups. The intervention groups were injected with different doses of PEX-168 intraperitoneally once a week for 12 weeks (low (LD), medium (MD) and high (HD)). Fasting blood glucose (FBG), body weight and food intake were measured from 1 to 12 weeks after PEX-168 injection. The serum insulin (INS), C-reactive protein (CRP), chemerin and omentin levels were measured after 12 weeks. Results: Compared with the HF group, the low dose of PEX-168 reduced the body weight of the mice in a short period of time (8 weeks), and the mice in the MD and HD groups showed a significant decrease in body weight ( P < 0.05). The low dose of PEX-168 could effectively improve the blood glucose and homeostasis model assessment of insulin resistance (Homa-IR) of the mice (FBG P < 0.05 INS, Homa-IR P < 0.001), but there was no significant difference between different doses ( P > 0.05). CRP levels in the MD and HD groups were significantly improved ( P < 0.05). The levels of serum chemerin and omentin in the intervention groups were also significantly improved ( P < 0.01), but there was no significant difference between the different doses ( P > 0.05). Conclusions: PEX-168 significantly reduced the body weight of simple obese mice and improved the insulin resistance. PEX-168 may regulate the expression of chemerin and omentin through its hypoglycaemic effect, and the weight-reducing effect of PEX-168 is unlikely to be the reason for the changes in both.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12902-021-00908-1

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The food intake of each group was compared for 12 weeks. Data are means ± s.d. Values were expressed as a box and whisker with minimum and maximal value. The figures showed the average daily food intake per week in each group
Fig. 1 The food intake of each group was compared for 12 weeks. Data are means ± s.d. Values were expressed as a box and whisker with minimum and maximal value. The figures showed the average daily food intake per week in each groupCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 9

Metadata

Authors
Guo, Z., Wu, Y., Zhu, L., Wang, Y., Wang, D., & Sun, X.
Affiliations
  • Yangzhou University (CN)
  • Northern Jiangsu People's Hospital (CN)
Corresponding author
Sun, Xiaofang
Venue
BMC Endocrine Disorders
Published
2021-12
Volume
21
Issue
1
Pages
245-245
ISSN
1472-6823 (ISSN-L)
OpenAlex
W4226060867
Cited by
9
References
34
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 3
FWCI
0.90
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Endocrine Disorders (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Yangzhou University
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
GLP-1 receptor agonists, simple obesity, insulin resistance, weight loss, chemerin, omentin, adipokines, C-reactive protein, inflammation, high-fat diet-induced obesity, fasting blood glucose, HOMA-IR
MeSH terms
Animals, Disease Models, Animal, Hyperinsulinism, Hypoglycemic Agents, Inflammation, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, Peptides, Polyethylene Glycols, Mice, Adipokines, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PEX-168 improves insulin resistance, inflammatory response and adipokines in simple obese mice: a mechanistic exploration. https://app.cochat.ai/papers/10.1186/s12902-021-00908-1
The paper
Guo, Z., Wu, Y., Zhu, L., Wang, Y., Wang, D., & Sun, X. (2021). PEX-168 improves insulin resistance, inflammatory response and adipokines in simple obese mice: a mechanistic exploration. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-021-00908-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.